About AmpTec
AmpTec is a Healthcare company based in Hamburg (Germany) founded in 2005 by Guido Krupp and Peter Scheinert, and was acquired by Merck in January 2021. Provider of products for RNA biology. Its chief executive, as recorded, is Peter Scheinert. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Reagents and Kits and Genomics.
Company details
AmpTec was founded in 2005 and is based in Hamburg, Germany. Operations focus on the biotechnology sector, where RNA isolation kits, mRNA amplification kits, guide RNAs for CRISPR applications, synthetic long RNAs and DNAs, and functional mRNAs are developed and distributed. The portfolio supports research in RNA-related fields through these specialized offerings.
- Headquarters Hamburg, Germany
- Founders Guido Krupp, Peter Scheinert
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website amp-tec.com
- Social LinkedIn
- Acquired by Merck (Jan 2021)
Funding Insights of AmpTec
- Total Rounds 3
- Last Round Grant — $40,511
- First Round $45,183
(Mar 2020)
- Investors Count 1
All 3 funding rounds of AmpTec with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec 2021 | $40,511 | Grant | – | – | |
| Feb 2021 | $102,381 | Grant | – | – | |
| Mar 2020 | $45,183 | Grant | – | – |
2 investors in total: 2 institutional.
Investors in AmpTec
AmpTec has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Merck and European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium | |
Merck is engaged in science and technology solutions globally. | 1668 | merckgroup.com | Darmstadt, Germany |
Investor details for AmpTec
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of AmpTec
2 people are tracked at AmpTec (2 in leadership).
| Name | Role | Group |
|---|---|---|
Guido Krupp | Co-Founder | Leadership |
Peter Scheinert | Co-Founder & CEO | Leadership |
Complete people profiles for AmpTec
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of AmpTec
4 dated milestones of AmpTec across 16 years, from founding to its latest funding, stage changes and deals.
- Founded AmpTec is founded.
- Funding First funding round of $45K.
- Exit Acquired by Merck.
- Funding Latest funding round, Grant, of $41K.
Web traffic of AmpTec
The website of AmpTec (amp-tec.com) receives about 2.3K visits a month.
- Monthly visits2.3K
▲ 17.1% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Amptec
Complete news archive for AmpTec
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about AmpTec
AmpTec was founded in 2005 and raised its 1st funding round 15 years after it was founded.
AmpTec is headquartered in Hamburg, Germany. It is registered at Hamburg, Hamburg, Germany.
Peter Scheinert is the CEO of AmpTec, as recorded in our data. They have also founded this company.
AmpTec was founded in 2005 and is based in Hamburg, Germany. Operations focus on the biotechnology sector, where RNA isolation kits, mRNA amplification kits, guide RNAs for CRISPR applications, synthetic long RNAs and DNAs, and functional mRNAs are developed and distributed. The portfolio supports research in RNA-related fields through these specialized offerings.
AmpTec has 2 investors. Key investors include Merck, and European Union.
Yes. AmpTec was acquired by Merck in January 2021.